The Story

My 16 year-old son was diagnosed with autism at age 2. For the last 14 years I have researched autism in hopes of finding ways to manage my son’s most difficult symptoms and improve the quality of his life and my family’s life. Although my background is not medicine, I used books, conferences and mainstream medical literature to educate myself on this topic. My research led me to develop a hypothesis about the cause of certain of the most troubling symptoms of autism. I also came up with a novel treatment approach from mainstream scientific and medical research in an area unrelated to autism. After presenting my research findings, I partnered with my son’s doctor (Dr. Eric Hollander, Director of the Seaver and New York Autism Center of Excellence and Chair of the Department of Psychiatry at Mount Sinai Medical Center in New York) to obtain the treatment agent and we began to treat my son. The results have been dramatic. My son’s most extreme behaviors, including self-abuse (head hitting, hand biting), agitation, aggression, anxiety, obsessive/compulsive thoughts and behaviors, impulsivity, perseveration, behavioral inflexibility, extreme sensitivity to external stimuli, and “stimming” were completely eliminated 10 weeks into the therapy, and have not returned for 15 months now. The treatment involves a living organism, not a drug.

Autism is a behaviorally defined disorder. The behaviors present in autism can be grouped into three core symptom “domains”. The first deals with communication and language deficits, the second with social deficits, and the last with restricted interests and compulsivity. In this website when I refer to “symptoms” I am referring to the symptoms in this last domain, including:

  • Self abusive behavior (head hitting, hand biting)
  • Agitation, aggression and anxiety
  • Obsessive/compulsive thoughts and behaviors
  • Behavioral inflexibility and extreme desire for “sameness”
  • Low frustration tolerance
  • Impulsivity
  • “Stimming”
  • Extreme sensitivity to external stimuli

The results were so remarkable that we have filed an application with the NIH for a double blind, placebo controlled clinical trial of this new treatment.

At Dr. Hollander’s request I presented this material to the research team at Mount Sinai in November, 2006 and will be presenting it again at the Seaver Autism Center of Excellence annual autism research conference on October 28th, 2007 at Mount Sinai Medical Center in New York City.